Global Integration of Pre-clinical Chemistry and Biology Data – Challenges and Benefits. Jayne...
-
Upload
adam-knight -
Category
Documents
-
view
214 -
download
1
Transcript of Global Integration of Pre-clinical Chemistry and Biology Data – Challenges and Benefits. Jayne...
Global Integration of Pre-clinical Global Integration of Pre-clinical Chemistry and Biology Data – Chemistry and Biology Data – Challenges and Benefits.Challenges and Benefits.
Jayne Cartmell Bowden, Ph.D.
Global Program Manager
Abbott Laboratories.
OverviewOverview
Discovery IT at Abbott - 1999 Project deployment and timelines Status details Impact TDB savings TDB metrics Lessons learned
Abbott Discovery IT - 1999Abbott Discovery IT - 1999
Biologists, chemists or ‘Paper-shufflers’? Frequent duplicate, manual entry of data
-slow, tedious, error-prone. Limited viewing and sharing of data. Out-of date Structure-Activity Relationships. Data scattered through-out Discovery Lack of standard tools made data sharing a
challenge… Excel, 4D, Ark, Access, Word, Accord, etc.
Consultant ReportConsultant Report
Tripos conducted IT analysis of Discovery data manipulation.
Abbott needed a system for projects to store and retrieve all project-related data…
…make project decisions wisely and quickly via ready access to accurate information.
Reduce ‘time-to-market’ and increase time under patent protection.
Reduce project costs via increased productivity. Abbott would save between $1.25 MM and $10 MM per
year if such a database system was in place.
““Integration”….Integration”….
‘…a process in which separately produced components are combined…’
Integration of Discovery dataIntegration of Discovery data
“In which assays has this compound/structure been run?” Effective access to project compound information -
structures, chemical properties and biological data is critical for productive drug discovery.
ChemicalProperties
BiologyData
In vitro In vivoPK
ADME
ChemicalStructure
RequirementsRequirements
Central, shared data repository.
Easy desktop access. Creation of SARs
including chemical structures and data.
Standard report generation by the scientists.
Data should be secure but not restricted.
Distinction made between published and unpublished data.
Storage of raw data avoids having to re-load data and provides data context.
Agreed on terminology. Minimal customization. Flexible – configurable
by scientists.
Therapeutic Area Database (TDB)Therapeutic Area Database (TDB)Assay Explorer
ISIS/Base
ISIS for Excel
Calculation Model
Export
Curve Fit
Reader Format
Data
Rollout Process and Timelines Rollout Process and Timelines
TDB rollout cycle (9 weeks)2 Projects deployed in parallel (23 AP Projects in total)
1 2 3 4 5 6 7 8 9 10 11
RequirementsRequirements
DevelopmentDevelopmentTestTest
FinalFinal
TrainTrain TrainTrain
DEV PRD
Go Live
1.5 days training for each scientist (detailed user manuals)
Global TDB StatusGlobal TDB Status
Abbott Park Deployment to all 23 projects complete (07/03)
Germany - Deployed October, 2002 Massachusetts - Deployed March, 2003 Support ramp-down and subsequent roll-outs on-going Positive feedback from Discovery scientists…
“…TDB is a huge time-saver…”
“…far superior to our old database…”
“…searching..is a huge improvement…”
TDB ImpactTDB Impact
Automated data entry (= less error). Updated data immediately accessible (= accurate). On-the-fly generation of SAR tables (= current). More time to focus on science. Broadens scope of data review. Facilitates research collaborations. Allows Discovery executives to monitor progress. Access to all Discovery data – globally. Terminology and standards applied across all sites. Data permanently accessible and understandable. Ability to perform tasks not possible before TDB.
TDB Impact – TDB Impact – Hard SavingsHard Savings
Estimate that IT support costs have been halved. Scientists at AP were queried one month after TDB launch. Based on 40 hour week, 48 weeks/year; on average, for one
project, hours saved…
Per Project Hours/wk $/year
Biologists (5) 27.5 181 000
Chemists (6) 6 40 000
Biology Group Leader 6 40 000
Chemistry Group Leader 1.5 10 000
Project Leader 1.5 10 000
Total 281K/yr
TDB Usage 2003TDB Usage 2003
0
20
40
60
80
100
120
140
160
180
200
220
Assay Explorer
ISIS
Jan Feb Mar Apr
Ave
rgae
nu
mb
er o
f d
aily
lo
g o
ns
May Jun Jul
Lessons Learned Lessons Learned
Ensure accurate and realistic scope verification. Thorough user testing is critical. Use realistic cost estimates. Do not underestimate the requirement for
detailed scientist training. Take frequent ‘reality-checks’. Effectively manage the scientists expectations
and the importance of their role in the deployment process.
Factors that helped usFactors that helped us
Executive support TDB team dedication and work ethic Scientific administrator TDB team experience and knowledge In-house trainers Documentation Support process Scientists on board
Thank-you….Thank-you….
LudwigshafenAgnes Metanomski
Alfred StefanGunther Stumpf
Heinz-Peter VogelJonathan Bosley (MDL)
Martine HeinrichPeter GruenerPeter Hellmann
Susanne BuechlerTom Marron
Uwe Christman
WorcesterAlan WilliamsBill George
Chris SprangelJoanne Kamens
Keith GlavinKeith Huss
MDL - SponsorsBill Balke
Debra ToburenLars BarfodMike Drake
Roger AbrahamSara BertschSeth Pinsky
Abbott ParkAlbert Crescenzo (MDL)
Brett Erkman Brian Devendorf Cynthia Collins
Dan MendroDevin Ridge
Diana Pell (MDL)Eric Schaefer
Faisal Waheed Jack Zhi
John Burns (MDL)John Crary (MDL)
John McCarthy (MDL)Julia Donavant
Karunakar ChikotiKelly Below (MDL)
Kim Davis Larry BuchananLeonard Sagalov
Matt Gianni (MDL) Mike Edwards (MDL)Ron Delmendo (MDL)
Subhash Nigam Zafar Ahmed
Abbott Park - SponsorsDon Halbert
Jim SummersJuergen Seega
Randy ChenBob Hogan
Thank-you….Thank-you….
Chris Butler
David Bacino
Fernando Egea
Gary Young
Grace Chiou
Jin Liu (MDL)
Karen Alexander
Manli Zheng
Martin Markley
Mike Karrmann
Omar Kazi
Ramesh Thangarajan
Tom Brady (MDL)
Kalyan Chintagunta